English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 16 October 2024, 15:36 HKT/SGT
Share:
Fosun Secures EUR670 Million for Completion of Ageas Sale

HONG KONG, Oct 16, 2024 - (ACN Newswire) - According to Ageas's press release, BNP Paribas notified Ageas on October 3, 2024, that its current shareholding in Ageas reached 10.91%. This change in shareholding is based on the agreement reached between BNP Paribas and Fosun International on April 14, 2024. Fosun International entered into an agreement with BNP Paribas to sell up to 15,401,253 shares of AGEAS SA/NV for a total consideration between EUR626 million and EUR670 million.

Source familiar with the matter stated that Fosun International acquired Ageas shares at a low price in its early years. Dividends over the years and proceeds from the disposal have yielded Fosun a considerable return. The transaction was completed on October 3, 2024, and Fosun has received a full payment nearly EUR670 million in cash, the source said.



Topic: Press release summary Sectors: Daily Finance, Daily News, Healthcare & Pharm, Banking & Insurance, Hospitality
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
CITIC Telecom CPC Wins Two Awards, Celebrating 'Innovation Never Stops' for 25 Years, recognizing Cybersecurity & Innovation Excellence  
Feb 9, 2026 13:28 HKT/SGT
JCB Announces Collaboration with Resorts World Sentosa in Singapore  
Monday, February 9, 2026 1:00:00 PM
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026  
Monday, February 9, 2026 10:00:00 AM
playX Secures Industry-Leading Player Protection Through Landmark Insurance Partnership with Great American Insurance Group  
Feb 8, 2026 23:30 HKT/SGT
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.  
Feb 7, 2026 05:45 HKT/SGT
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets  
Feb 6, 2026 17:45 HKT/SGT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share  
Feb 6, 2026 17:01 HKT/SGT
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization  
Feb 6, 2026 16:34 HKT/SGT
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis  
Feb 6, 2026 14:17 HKT/SGT
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025  
Feb 6, 2026 13:13 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575